Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin II during the acute phase of experimental renal hypertension.
D000409:Alanine; D000804:Angiotensin II / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D002714:Chlorisondamine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006977:Hypertension, Renal / Q000188:drug therapy / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012521:Sarcosine; D013997:Time Factors
D000804:Angiotensin II; D011433:Propranolol; D002714:Chlorisondamine; D000409:Alanine; D010646:Phentolamine; D012521:Sarcosine; D006145:Guanethidine